Metabolic vulnerabilities in pleural mesothelioma

July 31, 2026 | Comments Off on Metabolic vulnerabilities in pleural mesothelioma

Oncogenesis 2026 May 20 [Link] Sílvia Plans-Marin, Cristina Muñoz-Pinedo, Ernest Nadal Abstract Mesothelioma is a rare tumour of mesothelial origin that is often diagnosed at advanced stages. Despite recent approval…

The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

July 30, 2026 | Comments Off on The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

Diagnostic Cytopathology 2026 May 20 [Link] Suzanne M Selvaggi Abstract Background: Mesothelioma is a rare tumor that arises from the serosal cells lining the serous cavities, most commonly the pleura…

A case of diffuse malignant peritoneal mesothelioma: case report and literature review

July 29, 2026 | Comments Off on A case of diffuse malignant peritoneal mesothelioma: case report and literature review

Irish Journal of Medical Science 2026 May 19 [Link] Qian Zhao, Kangwei Xiong, Qiaoyun Wang, Lijiu Zhang Abstract Introduction: Diffuse malignant peritoneal mesothelioma (DMPM) is a very rare and life-threateningmalignant…

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

July 28, 2026 | Comments Off on Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

Translational Oncology 2026 July [Link] Seddig Momenkhan, Marie Morfouace, Vahan Kepenekian, Olivier Glehen, Laurent Villeneuve, Julio Oliveira, Sabine Tejpar, Sylvie Isaac, Juliette Fontaine, Jean-Yves Blay, Julien Péron, Nazim Benzerdjeb Abstract…

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

July 27, 2026 | Comments Off on Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

Translational Oncology 2026 July [Link] Seddig Momenkhan, Marie Morfouace, Vahan Kepenekian, Olivier Glehen, Laurent Villeneuve, Julio Oliveira, Sabine Tejpar, Sylvie Isaac, Juliette Fontaine, Jean-Yves Blay, Julien Péron, Nazim Benzerdjeb Abstract…

Cooperative response loops enhanced by histamine signaling during tumor-neutrophil crosstalk in pleural mesothelioma

July 24, 2026 | Comments Off on Cooperative response loops enhanced by histamine signaling during tumor-neutrophil crosstalk in pleural mesothelioma

Cell Reports 2026 May 26 [Link] Kuniyo Sueyoshi, Miwako Kakiuchi, Daisuke Komura, Hiroto Katoh, Asami Yamamoto, Susumu Kirimura, Iichiroh Onishi, Ayaka Asakawa, Hironori Ishibashi, Kenichi Ohashi, Kenichi Okubo, Shumpei Ishikawa…

Quantitative MRI-Based T Category in Pleural Mesothelioma: Analysis of a Large Real-World Cohort

July 23, 2026 | Comments Off on Quantitative MRI-Based T Category in Pleural Mesothelioma: Analysis of a Large Real-World Cohort

Academic Radiology 2026 May 15 [Link] Ritu R Gill, William G Richards, Emanuele Mazzola, Beow Y Yeap, Raphael Bueno Abstract Rationale and objectives: Accurate clinical staging in pleural mesothelioma (PM)…

Rethinking continuity in general practice for people with incurable illness: a qualitative case study of mesothelioma

July 22, 2026 | Comments Off on Rethinking continuity in general practice for people with incurable illness: a qualitative case study of mesothelioma

The British Journal of General Practice 2026 May 14 [Link] Emilie Couchman, Steph Ejegi-Memeh, Sarah Mitchell, Clare Gardiner Abstract Background: Continuity in general practice has clear benefits but is difficult…

Clinical utility and prognostic value of GATA3 in epithelioid malignant mesothelioma: a practical and cost-effective approach for resource-limited settings

July 21, 2026 | Comments Off on Clinical utility and prognostic value of GATA3 in epithelioid malignant mesothelioma: a practical and cost-effective approach for resource-limited settings

Journal of Clinical Pathology 2026 June 18 [Link] Dina Moustafa Thabit, Dalia M Thabet Abstract Aims: Distinguishing epithelioid malignant mesothelioma (EMM) from poorly differentiated lung adenocarcinoma (PD-LUAD) remains challenging, particularly…

Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes

July 20, 2026 | Comments Off on Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes

Pulmonary Medicine 2026 [Link] Santosh Basyal, Antony D Rawindraraj, Rahul Parajuli, Shardul Bhattarai, Laxman Wagle, Kritick Bhandari, Vikas Pathak Abstract Objective/background: Pleural fluid cytology remains a cornerstone in diagnosing malignant…

Categories